Obstructive Sleep Apnea Phenotypes and Management

Clinical Phenotypes

• The American Geriatrics Society notes that the Excessive Daytime Sleepiness (EDS) phenotype represents the classic presentation with prominent daytime somnolence, snoring, and witnessed apneas, most commonly seen in younger, obese patients 1, 2.
• Patients with the EDS phenotype typically present with Epworth Sleepiness Scale scores indicating significant drowsiness and report choking or gasping on awakening, according to the American Geriatrics Society 1.
• The EDS phenotype carries the highest cardiovascular mortality risk in untreated patients under age 50, making aggressive treatment essential, as stated by the American Geriatrics Society 1.
• Older adults with the Minimally Symptomatic Phenotype frequently present without obesity or excessive sleepiness despite significant apnea-hypopnea indices, and may primarily report nocturia, morning headaches, or cognitive impairment rather than sleepiness, according to the American Geriatrics Society 1, 3.
• The American Geriatrics Society recommends that OSA associated with resistant hypertension, heart failure, atrial fibrillation, or stroke represents a distinct high-risk phenotype, requiring particularly aggressive OSA treatment as untreated disease significantly worsens cardiovascular morbidity and mortality 1, 2, 3.
• Women with OSA commonly present with depression and hypothyroidism as prominent comorbidities, and prevalence increases dramatically in postmenopausal women, approaching rates seen in men, as noted by the American Geriatrics Society 1, 2, 3.

Anatomical Phenotypes

• The American Geriatrics Society states that neck circumference >17 inches in men and >16 inches in women indicates obesity-related airway compromise, and this phenotype responds particularly well to weight loss interventions, which improve apnea-hypopnea indices and symptoms 1, 3, 5, 6, 7.
• Retrognathia or micrognathia can cause OSA independent of obesity, and these patients require careful skeletal facial structure assessment and may benefit from mandibular advancement devices or surgical interventions, according to the American Academy of Sleep Medicine 1, 3, 8.

Management Approach

• The American College of Physicians recommends that all overweight and obese patients must be counseled to lose weight regardless of phenotype, as weight loss improves apnea-hypopnea indices and provides multiple health benefits beyond OSA treatment 5, 6, 7.
• CPAP remains the initial treatment for all OSA phenotypes based on moderate-quality evidence showing superior reduction in apnea-hypopnea index, arousal index, and improvement in oxygen saturation compared to all alternatives, as stated by the American College of Physicians 5, 6, 7.
• Mandibular advancement devices serve as alternatives for patients who refuse or cannot tolerate CPAP, particularly in mild-to-moderate disease, and custom-made dual-block devices fabricated by qualified dental providers are recommended, according to the American Academy of Sleep Medicine 5, 6, 8.
• Patients with the Cardiovascular Phenotype must receive aggressive counseling on significantly increased cardiovascular morbidity and mortality risks if they refuse OSA treatment, as stated by the American Heart Association 4.